Transcript Biotechnology Overview

WELCOME
THIRD
GLOBAL INDIAN ENTREPRENEURS
CONFERENCE, NEW YORK, September, 12-15th, 2002
Enormous Power – A Simple Use! ?
Definition
Any tecnique, product or process which
uses or is derived by using any living system
( plant, animal or microoragnism ),
to make or modify a product,
to improve plants or animals ,
to develop micro-organisms for specific use.
http://www.accessexcellence.org/AB/GG/biotechnology.html
Global Biotech
$3 Billion
Global Biotech $250 Billion. Bio Drugs $25 Billion
Sunday, April 21, 2002 IITOL Special Report
http://www.ey.com/GLOBAL/gcr.nsf/International/Biotech_Interview_Forum_-_Healthcare_-_Ernst_&_Young
Biotechnology- Global Promise
• The global biotechnology industry consists of
approximately 1,500 companies with industry
revenues of USD 18 billion and a market
capitalization exceeding USD 300 billion (1999
figures)
• The global biotechnology industry is expected to
grow to USD 400 billion by year 2005
• USFDA has approved 90 biotech products and over
2,200 products are in development
Bangalore Bio 2002
15-17th April
56 Exhibitors
300 Conference Delegates
12,000 Business Visitors
24, 000 general Visitors
The India Advantage
• India offers significant advantages for research in biotechnology
– Vast pool of talented and skilled man power
– Several leading research institutions
– Large and diverse gene pool - plant and human
– Vast and naïve patient population essential for new drug development
– Lower operational costs and technologies
– English as the accepted business language
– Complementary competencies in BT and IT making India well
positioned to exploit the Bio informatics wave
Biotechnology in India
• Biotechnology in India at a nascent stage
• Industry size estimated at US$ 3 billion (2002)
• Total biotech product market expected to grow 20% /year
•
The Indian biotech industry employs about 10,000 people;
this number is expected to grow to 20,000 by 2002
http://www.pharmabiz.com/specials/BioAsia/BioAsia1.asp
Biotech market in India, $m
2000
2005*
Vaccines
150
300
Antibiotics
225
275
Other
200
350
-
-
High-yielding & genetically modified
seeds
450
650
Other
100
200
Industrial products
-
-
Industrial enzymes
50
100
Amino acids, organic acids
150
200
Yeast and yeast products
150
250
Total
1,475
2,325
Source: Biocon India
*Forecast
Animal & health-care products
Agricultural products
COMPANY
PRODUCTS
Avesthagen Technologies
Plant genomics, GM Rice, Contract Research
Bangalore Genei
Restriction enzymes, plasmids, bacterial host strains, gel
documentation systems etc.
Bharat Biotech
Hep B Vaccine, GCSF, Interferon, Streptokinase
Biocon India
Enzymes, Lepuridine, Gamma Interferon, GCSF, Streptokinase,
Human Insulin, Monoclonal antibodies.
Clinigene International
Human genomics, Bioinformatics : Contract Clinical Research
Dr Reddy's(DRL)
GCSF, Interferon
Genotypic Technologies
Array based HTS contract research
Lotus Labs
Clinical trials: Contract research
MAHYCO
GM seeds: Bt Cotton
Panacea Biotech
Hep B Vaccine, Interferon, GCSF
Pro-Agro Seeds
GM Crops, Bt cotton
Photonics & Biomolecules
Laser based diagnostics
Reliance Industries
Stem cell research
Strand Genomics
Bioinformatics based contract research services
Synegene International
Disease Targets, r-DNA proteins, animal cell & tissue culture :
Contract Research
Syngenta
GM seeds
Wockhardt
Hep B Vaccine, EPO, GCSF, Human Insulin
X-Cyton
Recombinant diagnostics for AIDS, Hep C etc.
Growth areas for India
- Biogenerics
- Contract research
- Contract
manufacturing
- Clinical trials
- Genomics
–
Bio-informatics
–
Diagnostics
–
Drug discovery
and
–
Novel drug
delivery systems.
Biotechnology - Future Technology
• Biotechnology is a highly specialized segment of the life
sciences industry
• Benefits range from product development in pharmaceuticals
and healthcare, sustainable agriculture to solving problems
of land and water pollution
• Growing global population putting tremendous pressure on
large pharmaceutical companies for innovative new drugs
• Biotechnology industry seen as a key growth driver for the
pharmaceutical industry
Future Treatment
Plant Biotechnology
Hope we have a lot ahead
So close, but behind.
So dear, but with fear !
Nope, we can’t turn back
But to march ahead!
Thanks !
for your coperation in sharing information
Namastae !
The greatness in me is a reflection of Greatness in you !
Srinivasa K. Rao, Ph.D.,
Chief,
Bussiness & Technology Development.
SHANTHA BIOTECHNICS
Post Box No. 40137,Glen Oaks.
NEW YORK, 11005
Tel: 516 859 3010
Res : 718 347 9070
Email: [email protected]
SHANTHA GROUP:
Shantha Biotechnics Pvt. Ltd. Hyderabad, India
Shantha Marine, Chennai, India
Shantha West Inc, San Diego, USA